NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
Back to search
Official data from USPTO
HEALTHCARING CONVERSATIONS FOR CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEALTHCARING CONVERSATIONS FOR CLINICAL RESEARCH
ST13
US500000088448248Class
35, 42, 44
Filing
88448248
Registration
7269845
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
01/09/2024
Trademark type
Word
Nice classes
35, 42, 44
Filing date
05/28/2019
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
01/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2019-11-00
First use in commerce
2019-11-00
Drawing code
4
Owner type
03
Owner location
New Brunswick, NJ, US
Examiner
BECHHOFER, YOCHEVED D
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Johnson & Johnson
Representatives
Cheryl L. Foytlin JOHNSON & JOHNSON
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing information to healthcare professionals regarding recruiting patients for participation in clinical trials and optimizing patient engagement and experiences in the clinical trial process
Class 42
Providing information in the field of clinical trials and studies for human pharmaceuticals; providing information regarding clinical trials to healthcare professionals regarding how to optimize patient engagement and experiences in the clinical trial process
Class 44
Providing healthcare information to healthcare professionals regarding how to optimize patient engagement and experiences in the clinical trial process
Publications
History of USPTO decisions and trademark events.
54 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/05/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/04/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/17/2023
IUAF
USE AMENDMENT FILED
11/16/2023
EISU
TEAS STATEMENT OF USE RECEIVED
11/16/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/18/2023
EX5G
SOU EXTENSION 5 GRANTED
05/17/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/17/2023
EXT5
SOU EXTENSION 5 FILED
05/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/17/2022
EX4G
SOU EXTENSION 4 GRANTED
11/15/2022
EXT4
SOU EXTENSION 4 FILED
11/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/11/2022
EX3G
SOU EXTENSION 3 GRANTED
05/09/2022
EXT3
SOU EXTENSION 3 FILED
05/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/17/2021
EX2G
SOU EXTENSION 2 GRANTED
11/15/2021
EXT2
SOU EXTENSION 2 FILED
11/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/15/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/18/2021
EX1G
SOU EXTENSION 1 GRANTED
05/14/2021
EXT1
SOU EXTENSION 1 FILED
05/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/14/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/17/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/22/2020
PUBO
PUBLISHED FOR OPPOSITION
09/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/05/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/19/2020
GNFR
FINAL REFUSAL E-MAILED
03/19/2020
CNFR
FINAL REFUSAL WRITTEN
03/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/27/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2020
ALIE
ASSIGNED TO LIE
02/24/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/19/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/19/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2019
GNRT
NON-FINAL ACTION E-MAILED
08/20/2019
CNRT
NON-FINAL ACTION WRITTEN
08/20/2019
DOCK
ASSIGNED TO EXAMINER
08/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2019
NWAP
NEW APPLICATION ENTERED
05/31/2019
Continuous trademark protection
Get notified about every new filing that threatens HEALTHCARING CONVERSATIONS FOR CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.